From Josh Kannourakis, Baillieu Holst (via Mathan Somasundaram): We upgrade our rating on Greencross (ASX:GXL) to a BUY with a price target of $9.60 (prev

From Josh Kannourakis, Baillieu Holst (via Mathan Somasundaram): We upgrade our rating on Greencross (ASX:GXL) to a BUY with a price target of $9.60 (prev. $9.05) post recent share price weakness and a revision of our assumptions. We view GXL as a high quality speciality retailer that has: 1) A leading position within the $7bn and growing pet care market with a large acquisition pipeline (5% market share vs 20% target); 2) significant potential for margin expansion through realisation of synergies between the retail and vet businesses; and 3) sustainable revenue and earnings growth potential through its store rollout and co-location strategy. We are also encouraged by the potential revenue synergies within the merged group; only 20% of Greencross Vet customers shop at Petbarn and only 6% of Petbarn customers use Greencross (+Petbarn's loyalty program has ~1.1m members). See the full review on page 12. (VIEW LINK)


The Livewire Equities feed brings you a range of insights that relate to Australian equities

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.